Clinical drug investigationHumansAdministrationSublingualDrug ApprovalAmitriptyline
Sublingual Cyclobenzaprine: First Approval.
Hannah A Blair
Published: 202610.1007/s40261-025-01512-0
Abstract
TONMYA™ is a sublingual eutectic formulation of cyclobenzaprine being developed by Tonix Pharmaceuticals for the treatment of various conditions, including fibromyalgia, post-traumatic stress disorder (PTSD), acute stress disorder, major depressive d…
Preview only. Read the full abstract at the source